The global Oligonucleotide market size is predicted to grow from US$ 1629 million in 2025 to US$ 2963 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.

Infinity Market Research newest research report, the Oligonucleotide Industry Forecast looks at past sales and reviews total world Oligonucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide sales for 2025 through 2031. With Oligonucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oligonucleotide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    DNA
    RNA

Segmentation by Application:

    Gene Chip
    Electrophoresis
    Fluorescence In Situ Hybridization

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Abbott Molecular
    PerkinElmer
    SciGene Corporation
    Roche NimbleGen
    CytoTest
    Oligo Factory
    Danaher
    Thermo Fisher Scientific
    GE
    Merck
    Eurofins Scientific
    Agilent
    SUMITOMO CHEMICAL
    Bachem
    Sylentis

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oligonucleotide market?
What factors are driving Oligonucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide market opportunities vary by end market size?
How does Oligonucleotide break out by Type, by Application?